宣泰医药(688247.SH)：产品拟中选国家药品集中采购

Core Viewpoint - XuanTai Pharmaceutical (688247.SH) has participated in the 11th national centralized procurement organized by the National Organization for Drug Procurement Office, with its product Olaparib tablets expected to be selected in this procurement process [1] Group 1 - The company announced its involvement in the national centralized procurement bidding [1] - The procurement results were published on October 28, 2025, indicating the potential selection of Olaparib tablets [1] - The procurement document number for this process is GY-YD2025-1 [1]